- Home
- COCO vs IDYA Comparison
COCO vs IDYA Comparison
Compare COCO & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCO
- IDYA
- Stock Information
- Founded
- COCO 2004
- IDYA 2015
- Country
- COCO United States
- IDYA United States
- Employees
- COCO N/A
- IDYA N/A
- Industry
- COCO Beverages (Production/Distribution)
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- COCO Consumer Staples
- IDYA Health Care
- Exchange
- COCO Nasdaq
- IDYA Nasdaq
- Market Cap
- COCO 1.9B
- IDYA 2.2B
- IPO Year
- COCO 2021
- IDYA 2019
- Fundamental
- Price
- COCO $37.31
- IDYA $23.15
- Analyst Decision
- COCO Buy
- IDYA Strong Buy
- Analyst Count
- COCO 7
- IDYA 13
- Target Price
- COCO $33.50
- IDYA $53.67
- AVG Volume (30 Days)
- COCO 451.9K
- IDYA 890.1K
- Earning Date
- COCO 02-26-2025
- IDYA 02-18-2025
- Dividend Yield
- COCO N/A
- IDYA N/A
- EPS Growth
- COCO 56.82
- IDYA N/A
- EPS
- COCO 1.00
- IDYA N/A
- Revenue
- COCO $494,864,000.00
- IDYA $3,922,000.00
- Revenue This Year
- COCO $5.40
- IDYA N/A
- Revenue Next Year
- COCO $11.62
- IDYA $273.42
- P/E Ratio
- COCO $37.29
- IDYA N/A
- Revenue Growth
- COCO 3.21
- IDYA N/A
- 52 Week Low
- COCO $19.41
- IDYA $22.10
- 52 Week High
- COCO $37.88
- IDYA $47.74
- Technical
- Relative Strength Index (RSI)
- COCO 64.42
- IDYA 39.49
- Support Level
- COCO $34.46
- IDYA $22.10
- Resistance Level
- COCO $35.90
- IDYA $24.06
- Average True Range (ATR)
- COCO 1.29
- IDYA 1.04
- MACD
- COCO 0.10
- IDYA -0.15
- Stochastic Oscillator
- COCO 94.31
- IDYA 24.19
About COCO The Vita Coco Company Inc.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. Geographical presence of the company is in United States, Canada, Europe, Middle East, Africa, and the Asia Pacific regions.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.